The purpose of this e-learning module is to develop a consensus based on evidence from existing systematic reviews, to make health care providers aware of the value and the appropriateness of the use of FDG PET/CT positron emission tomography (PET) or PET combined with computed tomography (PET/CT) using 2-fluoro-deoxy-D-glucose (FDG) labeled with 18-Fluorine in the management of patients affected by cancer.
If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more.
A Guide To FDG PET-CT In Clinical Oncology
2019
E-learning Course
How to access
To access the e-learning module, simply click on 'Visit E-Learning Course' on the top.